TTR and AL amyloidosis: Moreover, there are now three amyloid fibril-binding antibodies being clinically evaluated for their ability to clear tissue amyloid in patients with ATTR or AL amyloidosis (NCT04360434, NCT03336580, NCT04512235, NCT04504825) [29,30,31,32].